Free shipping on all orders over $ 500

Simlukafusp alfa

Cat. No. M24793

All AbMole products are for research use only, cannot be used for human consumption.

Simlukafusp alfa Structure
Synonym:

FAP-IL2v

Size Price Availability Quantity
100ug USD 680  USD680 In stock
1mg USD 2040  USD2040 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Simlukafusp alfa (FAP-IL2v) is an immunocytokine comprising an antibody against fibroblast activation protein α (FAPα) and an IL-2 variant that only binds IL-2Rβγ. Isotype: human IgG1.

Chemical Information
CAS Number 1776942-10-9
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
References

[1] Inja Waldhauer, et al. MAbs. Simlukafusp alfa (FAP-IL2v) immunocytokine is a versatile combination partner for cancer immunotherapy

Related IL Receptor/Related Products
IL-17A modulator-2

IL-17A modulator-2 is a IL-17A modulator. IL-17A modulator-2 inhibits the biological action of IL-17A with a pIC50 of 8.3. IL-17A modulator-2 can be used for the research of diseases associated with modulation of IL-17A activity.

IL-15-IN-1 

IL-15-IN-1 is a potent and selective Interleukin 15 (IL-15) inhibitor, inhibiting the proliferation of IL-15-dependent cells with an IC50 of 0.8 μM.

IL-17 modulator 3 

IL-17 modulator 3 is an IL-17 modulator.

IL-17 modulator 4 

IL-17 modulator 4 is a proagent of IL-17 modulator 1.

IL-17A modulator-3 

IL-17A modulator-3 is a IL-17A modulator.

  Catalog
Abmole Inhibitor Catalog




Keywords: Simlukafusp alfa, FAP-IL2v supplier, IL Receptor/Related, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.